Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

GE HealthCare to acquire Sofie Biosciences for $1B

PUBLIC · GEHCSep 13, 2026about 2 hours ago

Acquiring Company

GE HealthCare Technologies

Acquired Company

SOFIE BIOSCIENCES, INC.

ChicagoCulver CityOtherInformation TechnologyBiotechnologyHealth CareMedicalBiotechnology

Description

GE HealthCare is in advanced discussions to acquire Sofie Biosciences for approximately $1 billion. This acquisition aims to enhance GE HealthCare's offerings in radioactive diagnostic agents for medical imaging. The deal could significantly boost revenue potential by merging imaging equipment sales with diagnostic agents. The transaction may be announced soon, pending the outcome of ongoing negotiations.

Company Information

Company

GE HealthCare Technologies

Location

Chicago, Illinois, United States

About

GE HealthCare Technologies Inc. is a global medical technology company specializing in pharmaceutical diagnostics, imaging analytics, and digital solutions. With a focus on precision care strategy, GE HealthCare aims to deliver innovative digital solutions across care pathways for more precise, connected, and efficient care across disease states.

Don't miss GE HealthCare Technologies's next move

Get an email the moment GE HealthCare Technologies makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Peter
Senior decision-maker at this company
••••••••@••••••••

See Peter's verified email →

Agnieszka
Senior decision-maker at this company
••••••••@••••••••

See Agnieszka's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for GE HealthCare Technologies's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired SOFIE BIOSCIENCES, INC.?

SOFIE BIOSCIENCES, INC. was acquired by GE HealthCare Technologies, based in Chicago. The deal was reported on September 13, 2026. GE HealthCare Technologies Inc. is a global medical technology company specializing in pharmaceutical diagnostics, imaging analytics, and digital solutions. GE HealthCare Technologies is publicly traded (GEHC) and operates in Other.

When did GE HealthCare Technologies acquire SOFIE BIOSCIENCES, INC.?

GE HealthCare Technologies's acquisition of SOFIE BIOSCIENCES, INC. was reported on September 13, 2026. GE HealthCare is in advanced discussions to acquire Sofie Biosciences for approximately $1 billion. This acquisition aims to enhance GE HealthCare's offerings in radioactive diagnostic agents for medical imaging. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does SOFIE BIOSCIENCES, INC. do?

Sofie Biosciences is a molecular imaging company focused on empowering people with new PET technologies. It is privately held, operating in Biotechnology, and is based in Culver City.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.